Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview of bronchiolitis.

May S Chehab1, Hend A Bafagih, Maha M Al-Dabbagh

  • 1Department of Pediatrics, Armed Forces Hospital, PO Box 7897, Riyadh 1159, Kingdom of Saudi Arabia. maychehab@hotmail.com

Saudi Medical Journal
|March 17, 2005
PubMed
Summary

Respiratory syncytial virus (RSV) causes significant infant infections, influenced by viral and host factors. Supportive care is primary, but early adjunctive therapies may aid airway obstruction in severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to surviving sepsis guidelines among pediatric intensivists. A national survey.

Saudi medical journal·2017
Same author

Septic pulmonary embolism secondary to Staphylococcus aureus septic thrombophlebitis in a pediatric patient.

Saudi medical journal·2013
Same author

Can we reduce mortality in sepsis?

Saudi medical journal·2004
Same author

Pediatric living-related liver transplantation in Saudi Arabia.

Saudi medical journal·2002
Same author

Living-related liver transplantation for Crigler-Najjar syndrome in Saudi Arabia.

Clinical transplantation·2002

Area of Science:

  • Virology
  • Pediatrics
  • Immunology

Background:

  • Respiratory syncytial virus (RSV) is a common cause of infant respiratory infections.
  • RSV pathogenesis involves viral factors (e.g., strain virulence) and host factors (e.g., asthma history, immune status).
  • Epithelial cell responses, including cytokine and chemokine release, drive inflammation during RSV infection.

Purpose of the Study:

  • To review the complex factors influencing RSV infection and its treatment in infants.
  • To discuss current and emerging therapeutic strategies for RSV bronchiolitis.

Main Methods:

  • Literature review of RSV pathogenesis and treatment modalities.
  • Analysis of viral and host interactions in RSV disease.
  • Evaluation of supportive care and adjunctive therapies for RSV bronchiolitis.

Main Results:

  • RSV infection is multifactorial, involving viral virulence, inoculum size, and host susceptibility.
  • Inflammatory responses initiated by epithelial cells are central to RSV-induced airway disease.
  • Supportive care (oxygen, fluids) remains the cornerstone of RSV bronchiolitis management.
  • Emerging evidence suggests early adjunctive therapies can benefit infants with airway obstruction, particularly in severe cases.

Conclusions:

  • RSV bronchiolitis treatment is challenging due to its complex etiology.
  • While supportive care is essential, early and judicious use of adjunctive therapies may improve outcomes for specific patient groups.
  • Further research into targeted therapies for RSV is warranted.

Related Experiment Videos